CompletedNot Applicable

BRAVA: Building Resilience and Attachment in Vulnerable Adolescents

Canada99 participantsStarted 2021-04-12

Plain-language summary

The prevalence of suicidal ideation (SI) among adolescents in North America is high, making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping skills and relationships. BRAVA is a novel brief group intervention for adolescents with mild to moderate SI and their caregivers; youth are taught skills for coping and relating more effectively with others. Caregivers learn about adolescent development, effective parenting and the importance of connection. The goal of the randomized controlled trial is to assess the efficacy of a virtually-delivered, brief group intervention for adolescents with mild to moderate SI and their caregivers in reducing SI.

Who can participate

Age range13 Years – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adolescents 13 years old to 17.5 years old * Mild to moderate suicidal ideation (SI without plan or gesture; 1 on the HEADS-ED) (Cappelli, et al., 2012) * Interested in study participation * Access to an electronic device with internet and email capabilities, and a functioning camera and microphone Exclusion Criteria: * SI with plan or gesture (2 on HEADS ED; indicated plan or gesture) * Comorbid disorders (psychosis, schizophrenia, developmental disabilities, major substance abuse, and severe eating disorders). * Referring clinician has identified an externalizing disorder as a primary diagnosis or primary concern (e.g. Conduct Disorder) * Currently participating in regular psychotherapy at least one time per week * Currently under Children's Aid Society care * Currently in the CHEO ED on a Form 1 or Form 2, or placed on a Section 17. * Express difficulty with reading and writing

What they're measuring

Suicidal Ideation

Timeframe: 6 weeks

Trial details

NCT IDNCT04751968

SponsorChildren's Hospital of Eastern Ontario

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-05-25